269 related articles for article (PubMed ID: 14757613)
1. A prospective study of aspirin use and the risk for colorectal adenoma.
Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
3. Aspirin dose and duration of use and risk of colorectal cancer in men.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Wu K; Fuchs CS
Gastroenterology; 2008 Jan; 134(1):21-8. PubMed ID: 18005960
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
J Natl Cancer Inst; 2005 Mar; 97(6):457-60. PubMed ID: 15770010
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of aspirin and the risk of gastrointestinal bleeding.
Huang ES; Strate LL; Ho WW; Lee SS; Chan AT
Am J Med; 2011 May; 124(5):426-33. PubMed ID: 21531232
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of aspirin use and the risk of pancreatic cancer in women.
Schernhammer ES; Kang JH; Chan AT; Michaud DS; Skinner HG; Giovannucci E; Colditz GA; Fuchs CS
J Natl Cancer Inst; 2004 Jan; 96(1):22-8. PubMed ID: 14709735
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
[TBL] [Abstract][Full Text] [Related]
9. Aspirin and the risk of colorectal cancer in women.
Giovannucci E; Egan KM; Hunter DJ; Stampfer MJ; Colditz GA; Willett WC; Speizer FE
N Engl J Med; 1995 Sep; 333(10):609-14. PubMed ID: 7637720
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Relationships between aspirin dose and colorectal adenomas.
Ann Intern Med; 2004 Feb; 140(3):I24. PubMed ID: 14757630
[No Abstract] [Full Text] [Related]
11. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
12. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.
García-Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2001 Jan; 12(1):88-93. PubMed ID: 11138826
[TBL] [Abstract][Full Text] [Related]
13. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
[TBL] [Abstract][Full Text] [Related]
14. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
15. Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
Cao Y; Nishihara R; Wu K; Wang M; Ogino S; Willett WC; Spiegelman D; Fuchs CS; Giovannucci EL; Chan AT
JAMA Oncol; 2016 Jun; 2(6):762-9. PubMed ID: 26940135
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma.
Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
Clin Gastroenterol Hepatol; 2004 Aug; 2(8):704-12. PubMed ID: 15290664
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).
Tangrea JA; Albert PS; Lanza E; Woodson K; Corle D; Hasson M; Burt R; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A;
Cancer Causes Control; 2003 Jun; 14(5):403-11. PubMed ID: 12946034
[TBL] [Abstract][Full Text] [Related]
18. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
19. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
